83 results
8-K
EX-99.1
SMTI
Sanara MedTech Inc
13 May 24
Sanara MedTech Inc. Announces First Quarter 2024 Results
9:20am
offset by higher gross profit and lower R&D expenses. The Company generated Adjusted EBITDA of $0.3 million for the quarter ended March 31, 2024
8-K
EX-10.1
SMTI
Sanara MedTech Inc
18 Apr 24
Sanara MedTech Inc. Announces $55 Million Debt Facility
9:20am
from the taxable income of such Obligor, which, for the avoidance of doubt, shall take into account (i) losses available to offset such taxable income
8-K
EX-10.1
SMTI
Sanara MedTech Inc
5 Apr 24
Departure of Directors or Certain Officers
9:15am
under this Agreement shall be subject to offset to the extent permitted by law by the amount of actual damages, if any, caused to either Party by any
8-K
EX-99.1
7ufzh91pp28j zlt
25 Mar 24
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
4:37pm
8-K
EX-2.1
skz1q
2 Aug 23
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
9:20am
8-K
EX-10.2
o9gqel2b
2 Aug 23
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
9:20am
8-K
EX-2.1
5lehx4aab9zgo pur
5 Jul 22
Sanara MedTech Inc. Announces Closing of Scendia Biologics, LLC Acquisition
9:20am
DEFA14A
fth c914788euy4
29 Apr 22
Additional proxy soliciting materials
8:35am
8-K
EX-10.1
im4516h
29 Apr 22
Departure of Directors or Certain Officers
8:25am
8-K
EX-10.2
ornv jy1q2222j5y
29 Apr 22
Departure of Directors or Certain Officers
8:25am
8-K
EX-10.3
wzfyhpo s259fegjdps
8 Apr 22
Entry into a Material Definitive Agreement
4:15pm